PORTACCI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.068
AS - Asia 741
EU - Europa 607
SA - Sud America 157
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 46
Totale 2.728
Nazione #
US - Stati Uniti d'America 1.013
SG - Singapore 310
IT - Italia 250
BR - Brasile 122
CN - Cina 100
DE - Germania 98
HK - Hong Kong 95
BD - Bangladesh 67
RU - Federazione Russa 61
VN - Vietnam 61
FR - Francia 57
IN - India 34
GB - Regno Unito 32
CA - Canada 28
CI - Costa d'Avorio 19
NL - Olanda 14
PL - Polonia 14
MX - Messico 13
SE - Svezia 13
FI - Finlandia 12
ES - Italia 11
ID - Indonesia 11
IQ - Iraq 11
AT - Austria 9
AR - Argentina 8
JP - Giappone 8
LT - Lituania 8
ZA - Sudafrica 8
CO - Colombia 7
IE - Irlanda 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
MY - Malesia 6
TR - Turchia 6
EG - Egitto 5
IL - Israele 5
MA - Marocco 5
PK - Pakistan 5
SA - Arabia Saudita 5
BS - Bahamas 3
CH - Svizzera 3
CL - Cile 3
JO - Giordania 3
NI - Nicaragua 3
NP - Nepal 3
PH - Filippine 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LY - Libia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
Totale 2.619
Città #
Ashburn 170
Singapore 167
San Jose 119
Council Bluffs 93
Hong Kong 93
Milan 78
Los Angeles 48
Beijing 41
Dallas 39
New York 35
Munich 34
Columbus 29
Rome 27
Boardman 26
Falkenstein 25
Lauterbourg 23
Ho Chi Minh City 20
Abidjan 19
Buffalo 18
Chicago 17
Frankfurt am Main 17
Santa Clara 17
São Paulo 17
Chandler 16
Hanoi 13
Phoenix 13
Bari 11
London 11
Montreal 11
Helsinki 10
Orem 10
Warsaw 10
Brooklyn 9
Nuremberg 9
Florence 8
Houston 8
Stockholm 8
Tokyo 8
Baghdad 7
Elk Grove Village 7
Manchester 7
Atlanta 6
Kuala Lumpur 6
Naples 6
Ankara 5
Chennai 5
Denver 5
Jakarta 5
Johannesburg 5
Mexico City 5
Nyköping 5
Seattle 5
Tampa 5
Toronto 5
Vienna 5
Belo Horizonte 4
Brasília 4
Dublin 4
Haiphong 4
Mumbai 4
Olomouc 4
Rio de Janeiro 4
Amman 3
Amsterdam 3
Belford Roxo 3
Bologna 3
Buenos Aires 3
Calgary 3
Da Nang 3
Detroit 3
Düsseldorf 3
Erbil 3
Figino 3
Fiorenzuola d'Arda 3
Hải Dương 3
Lấp Vò 3
Medellín 3
Paris 3
Poplar 3
Pune 3
Riyadh 3
Roubaix 3
Salt Lake City 3
Sterling 3
Trani 3
Turin 3
Washington 3
Addis Ababa 2
Agrigento 2
Bauru 2
Bexley 2
Biberist 2
Bogotá 2
Boydton 2
Brescia 2
Brussels 2
Cairo 2
Campo Grande 2
Charlotte 2
Curitiba 2
Totale 1.550
Nome #
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 134
A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation 127
Advancing Care in Severe Asthma: The Art of Switching Biologics 107
Short-term Tezepelumab effectiveness in patients with severe asthma: a multicentre study 105
Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia 104
Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study 95
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma” 94
Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose 93
The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit 87
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 86
The Predictors of Long COVID in Southeastern Italy 86
Asthma and Fixed Airways Obstruction: Real Life Aspects 83
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure 83
Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study 81
Female gender and psychological profile of outpatients attending Post-COVID-19 follow-up: some preliminary results 81
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 80
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 79
Divergences in chronic cough management among healthcare professionals in Southern Italy: A comprehensive survey 79
Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry 76
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 74
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review 73
Role of Free Radicals in the Pathophysiology of OSA: A Narrative Review of a Double-Edged Sword 71
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience 71
Early Prediction of In-Hospital Mortality in Patients with Acute Infections: Development of the Acute Severity Infection Score (ASIs) 70
Can single-inhaler Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium therapy postpone or save biologics for severe asthma? 70
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development? 63
Real-life preliminary evidence for basophils as predictors of Tezepelumab response in severe asthma 47
Bridging Gaps in Occupational Respiratory Disease Management: A Comparative Survey of Pulmonologists and Occupational Physicians in Italy 44
The impact of PAP therapy first impression on short-term treatment adherence 44
Reply to "Have we reached our final destination with biologics in severe uncontrolled asthma?" 44
Diaphragm function in patients with asthma and healthy controls: A cross-sectional study 35
Type-2 severe asthma comorbidities in the era of biologics: time to rethink clinical response? 33
FeNO 350 mL/s: Unlocking the Small Airways to Achieve Clinical Remission in Severe Asthma-A Pilot Study 32
The impact of tezepelumab therapy on perceived asthma triggers: a multicenter real-life study 29
Steady Quiet Asthma Without Biologics: One-Year Outcomes of Single-Inhaler Triple Therapy for Severe Asthma with Small Airway Dysfunction 28
Effect of the Arg16Gly β2-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study 27
Super-Responders to Biologic Treatment in Type 2-High Severe Asthma: Passing Fad or a Meaningful Phenotype? 25
Reconsidering Gender in Asthma: Is It All About Sex? A Perspective Review 22
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study 20
Why Every Asthma Patient Tells a Different Story 14
Nationwide trends in AECOPD care in Italy before, during and after COVID-19: discrepancies between data sources and across regions 8
Physical activity levels and influencing factors in individuals with bronchiectasis: a cross-sectional study 7
High Concordance of E-Nose-Derived Breathprints in a Healthy Population: A Cross-Sectional Observational Study 6
Prescription patterns and clinical rationales for corticosteroid use in respiratory infections: A cross sectional survey of medical specializations 6
Electronic Nose-Based Exhaled Volatile Organic Compound Pattern Recognition and Multivariate Signal Analysis for Discriminating Idiopathic Pulmonary Fibrosis from Autoimmune Usual Interstitial Pneumonia 5
Totale 2.728
Categoria #
all - tutte 9.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202340 0 0 0 2 6 9 0 6 8 1 4 4
2023/202451 6 4 1 4 7 18 0 1 4 0 1 5
2024/2025491 22 9 0 21 15 38 35 62 11 55 74 149
2025/20261.890 191 54 97 197 271 143 196 46 213 185 122 175
2026/2027256 126 90 40 0 0 0 0 0 0 0 0 0
Totale 2.728